B6E Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Swedish Orphan Biovitrum AB (publ)

Watchlist Manager

Watchlist

Price: 30.66 EUR Market Closed

Market Cap: €9B

S	Swedish Orphan Biovitrum AB (publ) XBER:B6E	SE
P	People's Insurance Company Group of China Ltd F:PIR	CN
	Anika Therapeutics Inc NASDAQ:ANIK	US
D	Denka Co Ltd DUS:DIK	JP
D	Dollarama Inc OTC:DLMAF	CA
	MorphoSys AG NASDAQ:MOR	DE
S	Sonic Healthcare Ltd SWB:SAB	AU
	Asetek A/S F:A31	DK
G	Green Impact Partners Inc XTSX:GIP	CA
C	CSP International Fashion Group SpA F:IIT	IT
	Renascor Resources Ltd OTC:RSNUF	AU
	Centamin PLC F:7CT	JE
S	Suzano SA SWB:SPXB	BR
W	Woodside Petroleum Ltd OTC:WOPEF	AU
T	Theon International Plc AEX:THEON	CY
W	Wise Ltd NASDAQ:WSE	UK
G	Getlink SE OTC:GRPTF	FR

Profitability Summary

Swedish Orphan Biovitrum AB (publ)'s profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

78%

Strong 3Y Average Gross Margin

78%

Gross Margin is Increasing

77% > 78%

Exceptional Operating Margin

31%

Sustainable 3Y Average Operating Margin

24%

Operating Margin is Increasing

24% > 31%

Low Net Margin

Low 3Y Average Net Margin

10%

Declining Net Margin

16% > 5%

Exceptional Free Cash Flow Margin

15%

Strong 3Y Average Free Cash Flow Margin

12%

Free Cash Flow Margin is Increasing

Positive 3Y Average ROIC

19%

ROIC is Increasing

6% > 14%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.